• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Up 2.00% Nasdaq Up 1.66%

    Sarepta Therapeutics, Inc. (SRPT)

    -NasdaqGS
    12.35 Up 0.62(5.29%) Feb 12, 4:00PM EST
    Prev Close:11.73
    Open:11.83
    Bid:11.45 x 2500
    Ask:12.60 x 100
    1y Target Est:33.25
    Beta:0.887301
    Earnings Date:Feb 24 - Feb 29 (Est.)
    Day's Range:11.30 - 12.44
    52wk Range:10.20 - 41.97
    Volume:1,160,039
    Avg Vol (3m):1,965,680
    Market Cap:559.10M
    P/E (ttm):N/A
    EPS (ttm):-4.83
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Comparison

    Symbol% ChgMkt Cap
    SRPTUp 5.29%559.10M
    GSKUp 1.56%96.22B
    ALNYUp 4.55%5.05B
    ISIS 0.00%6.91B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):19,667.73
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-15) :-4.88
    Quarterly EPS Est (Dec-15) :-1.18
    Mean Recommendation*:2.1
    PEG Ratio (5 yr expected):12.00

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Sarepta Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery and development of RNA-based therapeutics for the treatment of rare, infectious, and other diseases. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback